ITIF Logo
ITIF Search

Publications: Stephen Ezell

February 3, 2025

A Bipartisan Success: Celebrating 40 Years of the Hatch-Waxman Act

The 1984 Hatch-Waxman Act revolutionized the U.S. pharmaceutical industry, successfully balancing the interests of pharmaceutical innovation and affordability by creating legal pathways for accelerated generic drug competition while extending patent protections and introducing data exclusivities that preserved incentives for novel pharmaceutical innovation.

January 28, 2025

Trump’s Proposed Tariffs on Taiwanese Semiconductors Would Backfire

Trump’s proposed 100% tariffs on Taiwanese chips would hike prices, hurt U.S. tech, help China, and alienate a key ally—without bringing jobs home.

January 7, 2025

Export Controls on AI Chips: Biden’s Overreach Risks U.S. Leadership in Tech

The Biden administration's proposed export controls would impose sweeping restrictions on chip exports, risking U.S. competitiveness while failing to effectively address national security concerns.

December 10, 2024

Chipping Away at Competitiveness: Why Tariffs Won’t Save U.S. Semiconductor Manufacturing

Reviving U.S. semiconductor manufacturing requires targeted solutions—not broad tariffs that raise costs and hinder global competitiveness.

December 9, 2024

America Can’t Afford to Lose the Early Cancer Detection Race to China

Again and again, America has pioneered new technologies and then frittered away its leadership—in sectors ranging from semiconductors and solar panels, to televisions and medical devices. We can’t afford to squander another lead in multi-cancer early detection (MCED) because of regulatory roadblocks.

December 4, 2024

Innovate4Health: The Power of Intellectual Property and Innovation in Solving Global Health Challenges

Many of the world’s biggest challenges are health challenges. The good news is that, more than ever, people are meeting these challenges with innovative solutions.

November 15, 2024

US-India Subnational Innovation Competitiveness Index

For policymakers to bolster the global competitiveness of their nations and regions, they first must know where they stand. This report benchmarks the 87 regions of India and the United States using 13 commonly available indicators of strength in the knowledge economy, globalization, and innovation capacity.

October 28, 2024

Evidence to Inform Biopharmaceutical Policy: A Call for Research on the Impact of Public Policies on Investment in Drug Development

The scope and magnitude of the trade-off between immediate savings from lower drug prices and future health benefits from clinical development remain poorly understood and quantified. To support rigorous evaluations and inform evidence-based policymaking, it is crucial to invest in this area through research grants and improved access to federal and private data.

October 23, 2024

Evidence-Based Biopharmaceutical Policymaking: Symposium Report

There is a need for more rigorous evidence and more recent, high-quality data to inform biopharmaceutical policymaking by shedding light on the relationship between pharmaceutical firms’ expectations of financial returns from new drugs and their ability to invest in further R&D to discover future generations of drugs.

September 20, 2024

Advancing US-Japan Economic Security Partnership and Countering Chinese Economic Coercion

The United States and Japan must make a concerted effort to mutually advance their economic security and counter Chinese economic coercion, while bringing other allied nations aboard the enterprise to the greatest extent possible.

Back to Top